Comparable findings have been observed in breast cancer cells, where SHCBP1 knockdown led to ERK1/2 pathway inhibition and CXCL2 upregulation, contributing to decreased colony formation and cell viability [46]. This evidence concerns the gene SHCBP1 and breast carcinoma.